Pharma Times
Subscription Required: Yes
Pharma Time delivers the latest updates, analysis, and insights on pharmaceutical industry developments, research, and policy changes.
Latest News
- Advanced therapies boost UK’s life sciences ambitions
- Santhera reports promising long-term data for AGAMREE in Duchenne muscular dystrophy
- CNX Therapeutics acquires Sativex from Jazz Pharmaceuticals
- bimekizumab data shows sustained benefits in hidradenitis suppurativa
- ProImmune unveils ProVE SL monomers to boost T cell research
- Alys Pharmaceuticals begins phase 1/1b trial of ALY-301 for chronic urticaria
- Sonoma Biotherapeutics reports promising early data from phase 1 rheumatoid arthritis trial